Related Experiment Video
Updated: Jul 16, 2026
05:31
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
A novel structure-based virtual screening model for the hERG channel blockers.
Lupei Du1, Minyong Li, Qidong You
1Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
Biochemical and Biophysical Research Communications
|March 3, 2007
Summary
This study developed a computational model to predict hERG channel blockade, a key factor in cardiac arrhythmia risk. The model uses molecular docking and simulations to assess drug safety, potentially reducing costly experimental testing.
Area of Science:
- Pharmacology
- Computational Chemistry
- Cardiovascular Science
Background:
- The hERG potassium channel is crucial for cardiac repolarization.
- Blockade of the hERG channel can lead to dangerous cardiac arrhythmias.
- Assessing hERG channel blockade is vital for drug safety evaluations.
Purpose of the Study:
- To investigate the binding of blockers to the hERG potassium channel.
- To develop a structure-based virtual screening model for predicting hERG channel blockade.
- To evaluate the potential pro-arrhythmic liability of new chemical entities.
Main Methods:
- Homology modeling of the hERG channel.
- Molecular docking simulations.
- Linear regression analysis using GoldScore fitness to evaluate blockade activities.
Main Results:
- A structure-based virtual screening model was established.
- The model accurately estimates pIC(50) values for various hERG channel ligands.
- Docked poses align with existing mutation data, validating the model's accuracy.
Conclusions:
- The developed model provides a cost-effective method for virtual screening.
- It can predict hERG channel blockade and assess cardiac liability of drug candidates.
- This approach aids in early-stage drug development by identifying potential safety concerns.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...